An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Ocular Therapeutix™ to Participate at Two Upcoming Investor Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Ocular Therapeutix, Inc. (Nasdaq: OCUL) will participate in two upcoming healthcare conferences: the Jefferies London Healthcare Conference on November 18, 2021, with on-demand access to a pre-recorded fireside chat, and the Piper Sandler 33rd Annual Healthcare Conference starting November 22, 2021. Management will have virtual investor meetings available. Interested investors can view the presentations through the company's website.
Positive
None.
Negative
None.
BEDFORD, Mass.--(BUSINESS WIRE)--
Ocular Therapeutix, Inc. (Nasdaq: OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will participate at the following conferences:
Jefferies London Healthcare Conference Presentation: Pre-recorded fireside chat will be made available on-demand beginning on Thursday, November 18th at 8:00 AM GMT / 4:00 AM ET 1x1 Meetings: Friday, November 19, 2021
Piper Sandler 33rd Annual Healthcare Conference
Presentation: Pre-recorded fireside chat will be available on-demand beginning on Monday, November 22nd at 10:00 AM ET 1x1 Meetings: December 1-2, 2021
Management will be available throughout the day for virtual investor meetings at both conferences. If you plan to attend at least one of the conferences and are interested in meeting with management, please contact your Jefferies of Piper Sandler representative.
The pre-recorded webcasts of the fireside chats at the Jefferies London Healthcare Conference and Piper Sandler 33rd Annual Healthcare Conference can be accessed by visiting the Investors section of the Company’s website at investors.ocutx.com.
About Ocular Therapeutix, Inc.
Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bioresorbable hydrogel-based formulation technology. Ocular Therapeutix’s first commercial drug product, DEXTENZA®, is an FDA-approved corticosteroid for the treatment of ocular inflammation and pain following ophthalmic surgery and ocular itching associated with allergic conjunctivitis. Ocular Therapeutix’s earlier stage development assets currently in Phase 1 clinical trials include OTX-TKI (axitinib intravitreal implant) for the treatment of wet AMD and other retinal diseases and OTX-TIC (travoprost intracameral implant) for the reduction of intraocular pressure in patients with primary open-angle glaucoma or ocular hypertension. Ocular Therapeutix is currently evaluating OTX-CSI (cyclosporine intracanalicular insert) for the chronic treatment of dry eye disease and OTX-DED (dexamethasone intracanalicular insert) for the short-term treatment of the signs and symptoms of dry eye disease in Phase 2 clinical trials. Ocular Therapeutix's first product, ReSure® Sealant, is an FDA-approved device to prevent wound leaks in corneal incisions following cataract surgery.
Media
Ocular Therapeutix Scott Corning Senior Vice President, Commercial
scorning@ocutx.com
Source: Ocular Therapeutix, Inc.
FAQ
What events will Ocular Therapeutix participate in November 2021?
Ocular Therapeutix will participate in the Jefferies London Healthcare Conference on November 18 and the Piper Sandler 33rd Annual Healthcare Conference starting November 22, 2021.
When will the fireside chats be available for Ocular Therapeutix?
The fireside chat for the Jefferies London Healthcare Conference will be available on-demand starting November 18, 2021, and the Piper Sandler conference chat will be available starting November 22, 2021.
How can investors access Ocular Therapeutix's presentations?
Investors can access Ocular Therapeutix's presentations by visiting the Investors section of the company's website.
What is the ticker symbol for Ocular Therapeutix?
The ticker symbol for Ocular Therapeutix is OCUL.
What are the dates for one-on-one meetings at the Piper Sandler Conference?
One-on-one meetings at the Piper Sandler 33rd Annual Healthcare Conference are scheduled for December 1-2, 2021.
